Managing antiplatelet and anticoagulant drugs in patients undergoing elective ophthalmic surgery. Authors' response

Br J Ophthalmol. 2014 Aug;98(8):1136-7. doi: 10.1136/bjophthalmol-2014-305527. Epub 2014 May 29.

Authors

Rajarshi Mukherjee¹, Christine A Kiire¹, Neil Ruparelia², David Keeling³, Bernard Prendergast², Jonathan H Norris¹

Affiliations

¹ Oxford Eye Hospital, John Radcliffe Hospital, Oxford University Hospitals NHS Trust, Oxford, UK.
² Department of Cardiology, John Radcliffe Hospital, Oxford University Hospitals NHS Trust, Oxford, UK.
³ Department of Haematology, John Radcliffe Hospital, Oxford University Hospitals NHS Trust, Oxford, UK.

PMID: 24876457
DOI: 10.1136/bjophthalmol-2014-305527

No abstract available

Keywords: Drugs.

Publication types

Letter
Comment

MeSH terms

Anticoagulants / therapeutic use*
Cataract Extraction / adverse effects*
Choroid Hemorrhage / prevention & control*
Humans
Platelet Aggregation Inhibitors / therapeutic use*

Substances

Anticoagulants
Platelet Aggregation Inhibitors